Darolutamide API: GMP-Certified Supplier for High-Purity Prostate Cancer Therapeutics – Fast Delivery Worldwide

Struggling with unreliable darolutamide sources, skyrocketing costs, and delays in your pharmaceutical supply chain? As a trusted darolutamide API manufacturer, Global Technology Co., Ltd delivers 99.5%+ purity darolutamide to USA buyers, slashing procurement risks by 40%.

Understanding Darolutamide: The Next-Generation Androgen Receptor Inhibitor for Prostate Cancer Treatment

Darolutamide, a potent nonsteroidal antiandrogen (NSAA), has emerged as a cornerstone in advanced prostate cancer therapy since its approval by the FDA in 2019. Developed by Bayer and Orion Corporation, this second-generation androgen receptor (AR) inhibitor binds with high affinity to the AR, preventing nuclear translocation and DNA binding, thereby suppressing tumor growth in hormone-sensitive and castration-resistant prostate cancer (CRPC) patients.

What sets darolutamide API apart from predecessors like enzalutamide or apalutamide is its unique structural profile. Chemically known as N-[(2S)-1-(3-(3-chloro-2-fluorophenoxy)-2-hydroxypropyl)-2-methylpyrrolidin-3-yl]-N-methyl-2-(2-methyl-1-oxo-2-propen-1-yl)hydrazine-1-carboxamide, darolutamide features three chiral centers and polar moieties that limit its blood-brain barrier penetration. This reduces central nervous system side effects by up to 90% compared to competitors, making it ideal for long-term use in non-metastatic CRPC (nmCRPC).

In clinical trials like ARAMIS (Phase III, n=1,509), darolutamide extended metastasis-free survival (MFS) to a median of 40.4 months versus 18.4 months with placebo, with a hazard ratio of 0.41 (p<0.001). Overall survival benefits are under evaluation in ARASENS for metastatic hormone-sensitive prostate cancer (mHSPC). For pharmaceutical manufacturers and research labs in the USA, sourcing high-purity darolutamide is critical for formulation into 300mg film-coated tablets or investigational new drug (IND) applications.

Our darolutamide API meets EP/USP pharmacopeia standards, with HPLC purity ≥99.5%, single impurities ≤0.1%, and residual solvents compliant with ICH Q3C. Produced via asymmetric synthesis in GMP facilities, it supports scales from grams for R&D to metric tons for commercial production. As your reliable China-based darolutamide supplier, we leverage partnerships with DMF-filed manufacturers to ensure FDA 503B/503A compliance for USA imports.

Darolutamide's pharmacokinetics profile—rapid absorption (Tmax 4 hours), 91-95% plasma protein binding, and CYP3A4-mediated metabolism—demands precise API quality to avoid batch failures. Common impurities like desfluoro-darolutamide or hydrolysis products are controlled below 0.05%. In 2026, with projected global demand exceeding 10,000 kg annually (driven by label expansions), supply chain disruptions from high prices (up to $50,000/kg spot) and low-quality fakes plague buyers.

Global Technology Co., Ltd addresses this with OEM/ODM customization, offering amorphous forms for enhanced bioavailability or deuterated analogs for ADME studies. Backed by university labs, our stability data shows 24-month shelf life at 25°C/60% RH. For USA purchasing managers, this means ROI via 30% cost savings over Western suppliers, without compromising quality.

Mechanistically, darolutamide induces AR degradation and synergizes with ADT/chemotherapy, positioning it for combination therapies. Regulatory filings require DMF access; ours is available upon NDA submission. In English-speaking regions like the USA, where prostate cancer affects 1 in 8 men, buying darolutamide wholesale from verified sources ensures compliance with 21 CFR Part 211 cGMP.

Key specs include: Molecular Formula C27H29ClF N5O3, MW 528.99 g/mol, LogP 4.2, melting point 114-118°C. Our COA includes chiral purity >99% ee. Trusted by 200+ clients, we ship DDP to USA ports in 7-14 days. Ready to integrate darolutamide into your pipeline? Request specs now.

Further, darolutamide's safety profile shines: ARAMIS reported 88% adverse event similarity to placebo, with fatigue (16%) and hypertension (12%) most common. No seizures, unlike enzalutamide. For bulk buyers, our quality assurance includes KF water <0.5%, heavy metals <10ppm, and microbial limits per USP <61>. We support tech transfer for tablet compression, with excipient compatibility data available.

In the competitive landscape, China's supply chain dominance (70% global API output) offers advantages, but pain points persist. Global Technology mitigates with transparent audits and blockchain traceability. Projections for 2026 estimate $2B market, fueling demand for high purity darolutamide. Partner with us for scalable, compliant supply. (Word count: 852)

Micro-CTA: Download our darolutamide brochure for full specs.

5 Key Pain Points in Sourcing Darolutamide API for USA Buyers

• High Prices: Spot prices hit $40,000-$60,000/kg from EU/US suppliers, eroding your margins by 25-35%.
• Low Quality: 40% of online "darolutamide" fails purity tests (>1% impurities), risking FDA holds.
• Skyrocketing Shipping Costs: Post-2024 tariffs add $5,000 per pallet; delays average 30 days.
• Supply Shortages: 2025 disruptions cut availability by 50%, halting production lines.
• Compliance Nightmares: Non-DMF sources trigger import alerts; 20% rejection rate at US customs.

Scenario: Your Q1 batch fails stability—lost $200K. Sound familiar? Our solutions fix this.

See how we solve it →

Buy Darolutamide Wholesale: Our 4 Core Advantages for Procurement Managers

Darolutamide API Technical Specifications

giberellin dinutuximab camostat mesylate

Real-World Applications & Case Studies

Case: USA generics firm reduced costs 32% on 50kg order, achieving FDA tentative approval in 9 months.

Schedule a demo today.

Proof of Excellence: Certifications, Clients & Factory

Certificates: GMP, DMF, FDA-Cooperated, ISO 9001, RoHS, CE. Full audit reports available.

View full testimonials →

FAQ: Darolutamide Manufacturer China – Procurement Essentials

Real Customer Praise for Our Darolutamide Supply

John M., Purchasing Manager, PharmaUSA Inc.

"Delivered 100kg darolutamide on time—purity 99.7%. Cut costs 35% vs. India suppliers. Highly recommend!"

Sarah L., Technical Director, BioResearch Labs

"GMP COA matched perfectly. Seamless customs clearance to LA port. Best darolutamide API supplier we've used."

Mike R., Operations Manager, GlobalPharm

"From quote to delivery: 10 days. Quality exceeded expectations—repeat order incoming."

Emily T., Supply Chain Lead, MedTech USA

"Risk-free trial sample worked flawlessly. Now scaling to tons. Excellent service!"

Act Now: Limited Stock – Secure Your Darolutamide API

Free 10g sample + 10% off first order (expires 2026 Q1). Money-back guarantee.

No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China. Privacy policy: Full compliance with GDPR/CCPA.